Phathom Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: PHATHealthcare
Live Phathom Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
Phathom Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$7.63Low
$7.66High
Markets Today
| Previous Close | $7.75 |
|---|---|
| Open | $7.63 |
| Volume | 146,839 |
| Day's Range | $7.63 - $7.66 |
| 52W Range | $7.66 - $18.31 |
| Market Cap | $622.13 M |
Historical Performance
| 1M Returns | -16.22 |
|---|---|
| 3M Returns | -28.77 |
| 6M Returns | -29.29 |
| 1Y Returns | -34.04 |
| 5Y Returns | -76.97 |
| 10Y Returns | NA |
Phathom Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $622.13 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $175.11 M |
| ROE TTM | N/A |
| EPS TTM | $-1.27 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-159.35 M |
| Profit Margin | -126.35 |
| Market Cap | $622.13 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $175.11 M |
| ROE TTM | N/A |
| EPS TTM | $-1.27 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-159.35 M |
| Profit Margin | -126.35 |
Phathom Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $28.52 M | $39.50 M | $49.50 M | $57.58 M | $58.30 M | $74.27 M |
| Gross Profit + | $24.80 M | $34.47 M | $43.31 M | $49.94 M | $46.30 M | $59.18 M |
| Operating Income | -$78.86 M | -$59.92 M | -$15.27 M | -$5.93 M | -$15.48 M | -$3.96 M |
| EBITDA | -$78.69 M | -$59.75 M | -$15.12 M | -$5.80 M | -$15.37 M | -$3.85 M |
| Interest Expense | -$18.07 M | -$17.52 M | -$16.11 M | -$16.42 M | -$15.80 M | -$15.10 M |
| Depreciation | $177.00 K | $172.00 K | $156.00 K | $128.00 K | $110.00 K | $114.00 K |
| Income Before Tax | -$94.32 M | -$75.81 M | -$29.97 M | -$21.15 M | -$30.37 M | -$17.58 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$94.32 M | -$75.81 M | -$29.97 M | -$21.15 M | -$30.37 M | -$17.58 M |
| Net Profit Margin | -330.71% | -191.91% | -60.55% | -36.73% | -52.09% | -23.67% |
Phathom Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $6.00 K | $6.00 K | $6.00 K | $6.00 K | $7.00 K | $8.00 K |
| Reserve & Surplus | -$1.36 B | -$1.43 B | -$1.46 B | -$1.48 B | -$1.51 B | -$1.53 B |
| Non-Current Liabilities | $558.55 M | $564.23 M | $569.70 M | $565.27 M | $517.03 M | $517.57 M |
| Current Liabilities | $74.03 M | $91.82 M | $93.12 M | $132.04 M | $125.04 M | $153.78 M |
| Total Liabilities | $632.58 M | $656.05 M | $662.82 M | $697.32 M | $642.08 M | $671.35 M |
| Fixed Assets | $1.35 M | $1.24 M | $1.16 M | $1.06 M | $1.02 M | $971.00 K |
| Current Assets | $264.90 M | $218.88 M | $207.78 M | $228.97 M | $276.57 M | $295.92 M |
| Total Assets | $294.21 M | $250.22 M | $240.29 M | $259.15 M | $305.12 M | $327.07 M |
Phathom Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$94.32 M | -$75.81 M | -$29.97 M | -$21.15 M | -$30.37 M | -$17.58 M |
| Operating Cash Flow | -$84.93 M | -$62.73 M | -$14.12 M | -$5.00 M | -$15.65 M | -$1.93 M |
| Investing Cash Flow | -$18.00 K | -$97.00 K | -$27.00 K | -$87.00 K | -$61.00 K | -$44.00 K |
| Financing Cash Flow | $0 | $80.00 K | -$271.00 K | -$97.00 K | $66.64 M | $3.55 M |
| Change in Cash | -$84.95 M | -$62.75 M | -$14.41 M | -$5.18 M | $50.93 M | $1.58 M |
Phathom Pharmaceuticals, Inc. Common Stock Return Calculator
The Phathom Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,259
Invested Amount$10,000
Est. Returns$-7,741
About Phathom Pharmaceuticals, Inc. Common Stock
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
Popular Stocks
FAQs
What is the share price of Phathom Pharmaceuticals, Inc. Common Stock today?
Phathom Pharmaceuticals, Inc. Common Stock (PHAT) share price as of September 18, 2026 is $7.60. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Phathom Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the Phathom Pharmaceuticals, Inc. Common Stock (PHAT) Share by opening an international trading account with Angel One.
How can I purchase Phathom Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing Phathom Pharmaceuticals, Inc. Common Stock (PHAT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Phathom Pharmaceuticals, Inc. Common Stock (PHAT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Phathom Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of Phathom Pharmaceuticals, Inc. Common Stock (PHAT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Phathom Pharmaceuticals, Inc. Common Stock?
The market capitalization of Phathom Pharmaceuticals, Inc. Common Stock on September 18, 2026, is $622.13 M.
In which sector Phathom Pharmaceuticals, Inc. Common Stock belongs?
Phathom Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Phathom Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in Phathom Pharmaceuticals, Inc. Common Stock (PHAT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
